COHORT Trial in Clinical Pelivc Lymph Node Metastatic Prostate Cancer

Status Active, not recruiting

Clinical Trial Summary

In local advanced prostate cancer patients with clinically positive metastatic regional lymph node, the optimal treatment is still unanswered. For these patients, radiotherapy combined with hormonal therapy or hormonal therapy alone are recommended. Recently, the reports from NCCB and SEER data showed that radiotherapy combined with hormonal therapy have better survivals than hormonal therapy alone. This randomized phase III trial compare hormonal therapy alone with combined hormone with radiotherapy in clinically pelvic lymph node metastatic prostate cancer.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03241537
Study type	Interventional
Source	Samsung Medical Center
Contact
Status	Active, not recruiting
Phase	Phase 3
Start date	January 15, 2016
Completion date	December 14, 2026

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT06315595` - Improvements in Dynamic Contrast-Enhanced MR Angiography and Perfusion
Withdrawn	`NCT05191017` - Study of NUV-422 in Combination With Enzalutamide in Patients With mCRPC	Phase 1/Phase 2
Completed	`NCT00255125` - Role of Soy Supplementation in Prostate Cancer Development	Phase 3
Terminated	`NCT02809690` - 18F-FMAU PET/CT in Diagnosing and Characterizing Prostate Cancer	Phase 1
Completed	`NCT06020287` - The Robot-Assisted Laparoscopic Radical Prostatectomy Combined Anterior and Posterior Approach
Recruiting	`NCT03572946` - Targeted Biopsy or Standard Biopsy for Clinical Significant Prostate Cancer Detection	N/A
Active, not recruiting	`NCT03344757` - Health Gatherings - For Your Health After Cancer	N/A
Recruiting	`NCT05137561` - Robotic-arm Assisted 68 Ga PSMA PET/CT Guided Prostate Biopsy Versus MR Directed TRUS Guided Prostate Biopsy	N/A
Recruiting	`NCT04792138` - Learning MRI and Histology Image Mappings for Cancer Diagnosis and Prognosis.
Completed	`NCT03702439` - Prostate Cancer Screening Trial Using Imaging
Completed	`NCT04852224` - Strength, Aging, and Memory in Prostate Cancer
Completed	`NCT01240551` - F-18 Sodium Fluoride in Prostate Cancer	Phase 2
Not yet recruiting	`NCT06430411` - Outcomes of Local Treatment for Oligometastatic Prostate Cancer Diagnosed Using PSMA PET Imaging: OLIGOMET Study
Recruiting	`NCT02436122` - Impact of Preoperative HbA1c Levels on Pathologic Features and Oncological Outcomes in the Patients With Prostate Cancer	N/A
Active, not recruiting	`NCT03493945` - Phase I/II Study of Immunotherapy Combination BN-Brachyury Vaccine, M7824, N-803 and Epacadostat (QuEST1)	Phase 1/Phase 2
Completed	`NCT04376008` - A Prospective Study Of Free-Hand Transperineal Image Fusion Targeted Biopsies Under Local Anesthesia	N/A
Recruiting	`NCT05252390` - NUV-868 as Monotherapy and in Combination With Olaparib or Enzalutamide in Adult Patients With Advanced Solid Tumors	Phase 1/Phase 2
Recruiting	`NCT06292897` - Using Tissue-based Spatial Data to Understand How Obesity-related Tumor Metabolites Fuel Prostate Cancer Progression
Recruiting	`NCT03819751` - MRI-targeted Biopsy of the Prostate: Software Versus Visual Registration in the Accuracy of Prostate Cancer Detection	N/A
Not yet recruiting	`NCT05460312` - Protein Kinase A in Prostate Cancer Tissue.